Dr. Megan Kalambo joins SurgMark
Dr. Megan Kalambo is a breast imaging radiologist at The University of Texas MD Anderson Cancer Center (MDACC) and Clinical Medical...
top of page
NEWS
Sep 91 min read
Marc Amyot joins SurgMark
Holds a Master degree in biochemistry from the Univerté du Québec à Montréal and is responsible for the clinical research operations. He...
Jan 232 min read
MedTech Start-up SurgMark announces FDA 510(k) Clearance for Biocompatible SchurSign® Tissue Marker
SurgMark GmbH today announced that the U.S. Food & Drug Administration (FDA) has issued a 510(k) premarket notification for its...
Nov 13, 20231 min read
SurgMark at MEDICA/COPAMED 2023
Biomaterial in breast cancer diagnostics: Hamburg-based start-up SurgMark presents SchurSign® Tissue Marker at MEDICA/COPAMED 2023...
Nov 1, 20232 min read
Revolutionizing Breast Cancer Diagnostics: SurgMark Introduces SchurSign® Tissue Marker at MEDICA/CO
The Future of Early Detection Unveiled In a significant stride towards redefining breast cancer diagnostics, Hamburg-based start-up...
Apr 23, 20232 min read
Medical technology start-up SurgMark aims to enter the US market
Press Release Medical technology start-up SurgMark aims to enter the US market FDA Approval Sought for Biocompatible SchurSign® Tissue...
Dec 1, 20211 min read
Production of the marker started
In December 2021, production of the marker could be started under GMP and cleanroom conditions. The first markers will be produced for...
Sep 28, 20211 min read
Dr Christine König elected to the BGB Board of Life Science Nord e.V.
Dr Christine König was elected by the members to the BGB Board of Life Science Nord (LSN) e.V. as treasurer. LSN has over 270 members...
bottom of page